Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Prostate Cancer and Prostatic Diseases|October 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancerPornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient GroupsAllison Makovec, Ava P Gustafson, Nishant Gandhi, et al.
Blood|June 8, 2012
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemiasNicholas A Zorko, Kelsie M Bernot, Susan P Whitman, et al.
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
Cancer Research Communications|January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic TargetingJohn R Lozada, Andrew Elliott, Mark G Evans, et al.
Cancer Research Communications|May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human MalignanciesCarly D Miller, John R Lozada, Nicholas A Zorko, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
Prostate Cancer and Prostatic Diseases|February 28, 2024
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient OutcomesNicholas A Zorko, Allison Makovec, Andrew Elliott, et al.
Blood|October 3, 2013
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human diseaseKelsie M Bernot, John S Nemer, Ramasamy Santhanam, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, et al.
Pageof 5